GATA1
Chr XXLRGATA binding protein 1
Also known as: CNSHA9, ERYF1, GATA-1, GF-1, GF1, HAEADA, NF-E1, NFE1
This transcription factor serves as a master regulator for red blood cell development and controls the switch from fetal to adult hemoglobin production. Mutations cause X-linked recessive hematologic disorders including dyserythropoietic anemia, thrombocytopenia, and beta-thalassemia, often presenting with combined blood cell abnormalities affecting red cells and platelets. The gene is highly constrained against loss-of-function variants (pLI 0.95, LOEUF 0.32), reflecting its critical role in hematopoiesis.
Definitive — sufficient evidence for diagnostic panels
Population Genetics & Constraint
gnomAD v4 — loss-of-function & missense intolerance
Highly LoF-intolerant (top ~10% of genes)
Mild missense constraint
The highest-scoring mechanism for this gene is loss-of-function (haploinsufficiency).
Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.
ClinVar Variant Classifications
0 submitted variants in ClinVar
Protein Context — Lollipop Plot
GATA1 · protein map & ClinVar variants
Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.
3D Protein StructureAlphaFold
External Resources
Links to major genomics databases and tools
Clinical Trials
Active and recruiting trials from ClinicalTrials.gov
Hypogonadotrophic Hypogonadism in Genetic Neurodevelopmental Conditions
RECRUITINGLong Term Beta Thalassemia Treatment: Findings From The Extension Period
ACTIVE NOT RECRUITINGExternal Resources
Links to major genomics databases and tools